← Back
US Customs / CBPCustoms TariffUSEUPublished: June 18, 2026
⚠️This content was analyzed by AI. Please verify with the original source.

USTR has initiated a Section 301 investigation into Germany's persistent underpayment for innovative pharmaceutical products.

[Impact on sellers shipping from Japan to EU] This is a US–Germany pharma trade dispute. Direct impact on Japan-origin cross-border sellers is currently limited, but escalation into retaliatory tariffs could affect EU-US supply chains. Please verify original

🔗 View Original

Original Text (Excerpt)

USTR Announces Initiation of Section 301 Investigation of Germany's Persistent Underpayment for Innovative Pharmaceutical Products. Source: https://ustr.gov/about/policy-offices/press-office/press-releases/2026/june/ustr-announces-initiation-section-301-investigation-germanys-persistent-underpayment-innovative
View Original →

Related Updates

US Customs / CBPCustoms TariffPublished: July 2, 2026

USTR is holding public hearings on proposed responsive actions under Section 301…

US Customs / CBPCustoms TariffPublished: July 2, 2026

The USTR is holding a public hearing on proposed responsive actions under a Sect…

US Customs / CBPCustoms TariffPublished: July 1, 2026

U.S. CBP announces that IRS quarterly interest rates for calculating interest on…

US Customs / CBPCustoms TariffPublished: June 28, 2026

USTR has initiated a Section 301 investigation into Vietnam's acts, policies, an…

US Customs / CBPCustoms TariffPublished: June 24, 2026

U.S. CBP indefinitely suspends the $800 de minimis exemption for all import mode…

Issue with this update?
← Policy Updates